Crown Bioscience Releases Scientific Posters Detailing Innovations in Preclinical Cancer Pharmacology Print
By GLOBE NEWSWIRE   
Thursday, 07 December 2017 04:36

Presentation of Posters by Expert Scientists Now Available On-Demand on Crown Bioscience’s Website https://www.crownbio.com/eortc17-posters

SANTA CLARA, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE)

Presentation of Posters by Expert Scientists Now Available On-Demand on Crown Bioscience’s Website https://www.crownbio.com/eortc17-posters

SANTA CLARA, Calif., Dec. 07, 2017 (GLOBE NEWSWIRE) --  Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company providing translational platforms to document.write( advance oncology, inflammation, cardiovascular and metabolic disease research, releases scientific posters narrated by leading scientists. These posters were presented at the vertical-align:baseline; recent AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics and are now available on-demand on Crown Bioscience’s website, https://www.crownbio.com/eortc17-posters.

Crown Bioscience presented more than a dozen scientific posters describing innovations in the background:transparent; field of preclinical cancer research at AACR-NCI-EORTC 2017. The most compelling work is now available on-demand and